© 2020 MJH Life Sciences and Drug Topics. All rights reserved.
June 26, 2020
Vaccine candidates for COVID-19 are going through clinical trials at a faster rate than for any other disease.
Officials with the FDA approved fenfluramine (Fintepla, Zogenix) oral solution, CIV for the treatment of seizures associated with Dravet syndrome in patients 2 years of age and older.
Check out this week's most important coronavirus-related news.
June 25, 2020
Demand for an affordable generic steroid soared after preliminary findings from a study showed it may be effective in reducing deaths from the coronavirus disease 2019 (COVID-19).
Existing surveillance networks can track influenza-like illness and lead to improved assessments on impact, prevalence, and severity of COVID-19.
The MMR vaccine may demonstrate some degree of protection against septic inflammation, a symptom of COVID-19, according to a team of experts.
In the newest episode of Over the Counter, 3 experts on professional burnout discuss the factors at play, and the impact the COVID-19 pandemic may be having on rates of pharmacist burnout.
Julie Ann Justo, infectious diseases clinical pharmacist and associate professor at the University of South Carolina College of Pharmacy, discusses the latest data from Gilead's trials for Remdesivir, a potential COVID-19 treatment.
June 24, 2020
Results of a PLOS ONE study determined a positive relationship between COPD and smoking and mortality rates from COVID-19.
Researchers have discovered a new type of vaccination, which has been tested in monkeys, that could improve and sustain protection against HIV.